Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel Bradbury currently holds 7,125 shares of AMYLIN PHARMACEUTICALS INC (AMLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Bradbury has been a net seller of AMLN stock. They have purchased $1.2M and sold $61.2M worth of shares.
Daniel Bradbury's most recent insider trade was on Sep 5, 2024, when they sold 1,425 shares at $29.02 per share.
Daniel Bradbury serves as Executive at AMYLIN PHARMACEUTICALS INC (AMLN). They have executed 902 insider transactions totaling $62.4M over their tenure at the company.
Daniel Bradbury holds the position of Executive at AMYLIN PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Daniel Bradbury has shown a selling trading pattern, with $1.2M in total purchases and $61.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel Bradbury was on May 6, 2024, when they sold $196.3K worth of CSTL shares. This transaction involved 7,967 shares at $24.64 per share.
Daniel Bradbury currently owns 7,125 shares of AMYLIN PHARMACEUTICALS INC (AMLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel Bradbury's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel Bradbury has 902 Form 4 filings on record as an insider at AMYLIN PHARMACEUTICALS INC.
Set alerts for Daniel Bradbury and 40,000+ other insiders.